Virchow, J. Christian
Hickey, Lisa
Du, Evelyn
Garin, Margaret
Funding for this research was provided by:
Teva Pharmaceuticals
Article History
Received: 11 November 2019
Accepted: 3 April 2020
First Online: 19 April 2020
Ethics approval and consent to participate
: Both trials were conducted in accordance with Good Clinical Practice guidelines, the Declaration of Helsinki, and local regulatory requirements. The relevant health authorities and local ethics committees or institutional review boards approved the study protocols. All patients provided written informed consent.
: Not applicable.
: JCV has lectured for and received honoraria from Allergopharma, ALK, Asche Chiesi, AstraZeneca, Avontec, Bayer, Bencard, Bionorica, Boehringer Ingelheim, Cipla, Essex/Schering-Plough, GSK, Janssen-Cilag, Laboratorios LETI, Meda Pharmaceuticals, Merck/MSD, Mundipharma, Novartis, Nycomed/ALTANA, Pfizer, Regeneron, Revotar Biopharmaceuticals, Sandoz/Hexal, Sanofi, Stallergenes, Takeda, Teva Pharmaceuticals, UCB/Schwarz Pharma, Zydus Cadila and possibly others and has participated in advisory boards for Asche Chiesi, Avontec, Boehringer Ingelheim, Essex/Schering-Plough, GSK, Janssen-Cilag, MSD, Mundipharma, Novartis, the Paul-Ehrlich-Institut, Revotar Biopharmaceuticals, Sandoz/Hexal, Sanofi, Takeda, TEVA, UCB/Schwarz Pharma and possibly others and has received grants from the Deutsche Forschungsgemeinschaft, Land Mecklenburg-Vorpommern, GSK, MSD. LH is a former employee of Teva Pharmaceuticals. MG and ED are employees of Teva Pharmaceuticals.